Prostate-Specific Antigen Response and Systemic T Cell Activation After In Situ Gene Therapy in Prostate Cancer Patients Failing Radiotherapy-Reference-Cited by-同舟云学术

Prostate-Specific Antigen Response and Systemic T Cell Activation After In Situ Gene Therapy in Prostate Cancer Patients Failing Radiotherapy

Published:2001-11 Issue:16 Volume:12 Page:1955-1967
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Miles Brian J.¹,Shalev Moshe¹,Aguilar-Cordova Estuardo²,Timme Terry L.¹,Lee Hon-Man¹,Yang Guang¹,Adler Howard L.¹,Kernen Kenneth¹,Pramudji Christina K.¹,Satoh Takefumi¹,Gdor Yehoshua¹,Ren Chengzhen¹,Ayala Gustavo³,Wheeler Thomas M.⁴,Butler Edward B.⁵,Kadmon Dov¹,Thompson Timothy C.⁶

Affiliation:

1. Matsunaga-Conte Prostate Cancer Research Center, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030

2. Gene Vector Laboratory, Texas Children's Cancer Center, Texas Children's Hospital, Houston, TX 77030

3. Department of Pathology, Baylor College of Medicine, Houston, TX 77030

4. Matsunaga-Conte Prostate Cancer Research Center, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030 and Department of Pathology, Baylor College of Medicine, Houston, TX 77030

5. Department of Radiology, Baylor College of Medicine, Houston, TX 77030

6. Matsunaga-Conte Prostate Cancer Research Center, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030; Department of Radiology, Baylor College of Medicine, Houston, TX 77030 and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104303401753204535

Reference25 articles.

1. Cytopathic effect of in situ gene therapy in prostate cancer

2. Pre-Existent Adenovirus Antibody Inhibits Systemic Toxicity and Antitumor Activity of CN706 in the Nude Mouse LNCaP Xenograft Model: Implications and Proposals for Human Therapy

3. Serum Prostate-Specific Antigen Profile Following Radiotherapy for Prostate Cancer: Implications for Patterns of Failure and Definition of Cure

4. Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer;Molecular Therapy: Oncology;2024-03

2. In Situ Gene Therapy;Current Gene Therapy;2021-12-23

3. Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer;Asian Journal of Urology;2021-07

4. Identification of lncRNA Signature Associated With Pan-Cancer Prognosis;IEEE Journal of Biomedical and Health Informatics;2021-06

5. Considering the potential for gene-based therapy in prostate cancer;Nature Reviews Urology;2021-02-26